Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

RENOVA Drug Profile

« Back to Dashboard

Which patents cover Renova, and what substitute generic drugs are available?

Renova is a drug marketed by Valeant Pharms North and is included in two NDAs. There is one patent protecting this drug.

The generic ingredient in RENOVA is tretinoin. There are twenty-four drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the tretinoin profile page.

Summary for Tradename: RENOVA

Patents:1
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list93
Patent Applications: see list9,701
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RENOVA at DailyMed

Pharmacology for Tradename: RENOVA

Ingredient-typeRetinoids
Drug ClassRetinoid
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms North
RENOVA
tretinoin
CREAM;TOPICAL021108-001Aug 31, 2000RXYesYes6,531,141► Subscribe ► Subscribe
Valeant Pharms North
RENOVA
tretinoin
CREAM;TOPICAL019963-001Dec 29, 1995RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: RENOVA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North
RENOVA
tretinoin
CREAM;TOPICAL021108-001Aug 31, 20004,603,146► Subscribe
Valeant Pharms North
RENOVA
tretinoin
CREAM;TOPICAL019963-001Dec 29, 19954,877,805► Subscribe
Valeant Pharms North
RENOVA
tretinoin
CREAM;TOPICAL019963-001Dec 29, 1995RE36068► Subscribe
Valeant Pharms North
RENOVA
tretinoin
CREAM;TOPICAL019963-001Dec 29, 19954,603,146► Subscribe
Valeant Pharms North
RENOVA
tretinoin
CREAM;TOPICAL021108-001Aug 31, 2000RE36068► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc